コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 and abnormal placentation (preeclampsia and intrauterine growth restriction).
2 lampsia, premature rupture of membranes, and intrauterine growth restriction.
3 -term), perinatal deaths, preterm birth, and intrauterine growth restriction.
4 sgenic mice showed fasting hyperglycemia and intrauterine growth restriction.
5 </=3-fold increased risk of preeclampsia and intrauterine growth restriction.
6 fetuses with long-term, chronic hypoxia and intrauterine growth restriction.
7 with structural malformations and linked to intrauterine growth restriction.
8 xy for the pathological process of interest, intrauterine growth restriction.
9 or gestational age and those with pathologic intrauterine growth restriction.
10 actor and placental growth factor levels and intrauterine growth restriction.
11 rent spontaneous abortion, preeclampsia, and intrauterine growth restriction.
12 gical deficits, hearing and vision loss, and intrauterine growth restriction.
13 ntal," which was preceded by preeclampsia or intrauterine growth restriction.
14 d nutritional status who were at low risk of intrauterine growth restriction.
15 e nutritional status who were at low risk of intrauterine growth restriction.
16 rths include pre-eclampsia or eclampsia, and intrauterine growth restriction.
17 iated with preeclampsia and fetal indication/intrauterine growth restriction.
18 reduce birth weight and increase the risk of intrauterine growth restriction.
20 ry tract (8/36 [22%] vs 2/71 [3%]; p=0.002), intrauterine growth restriction (34/37 [92%] vs 34/70 [4
21 , born after a preterm birth or secondary to intrauterine growth restriction, account for much of the
24 n and cardiovascular disease may result from intrauterine growth restriction and low birth weight ind
25 often leads to abortion, premature delivery, intrauterine growth restriction and low birth weight.
27 ctor to poor placental perfusion, leading to intrauterine growth restriction and preeclampsia, is the
28 rther distinguish placental dysfunction from intrauterine growth restriction and reveal a role for th
29 ic membranes of placentas from newborns with intrauterine growth restriction and underlying congenita
30 may also have a role in the investigation of intrauterine growth restriction and unexplained stillbir
31 as Turner's syndrome, Prader-Willi syndrome, intrauterine growth restriction, and chronic renal failu
33 logical processes that underlie miscarriage, intrauterine growth restriction, and pre-eclampsia, and
34 a, congenital transmission, pup viral loads, intrauterine growth restriction, and pup mortality compa
35 mice demonstrated increased amniotic fluid, intrauterine growth restriction, and reduced litter size
36 S) is characterized by recurrent fetal loss, intrauterine growth restriction, and vascular thrombosis
38 re collected in a Montreal, Canada, study of intrauterine growth restriction between May 1998 and Jun
40 utero in FASDEL mice and in another model of intrauterine growth restriction caused by ectopic expres
41 ontribute to strain-dependent differences in intrauterine growth restriction caused by reduced EGFR a
42 c mutation of the mouse Mtrr gene results in intrauterine growth restriction, developmental delay, an
44 ognitive impairment, behavioral alterations, intrauterine growth restriction, feeding problems, and v
45 8 group A versus 0 group B (P < 0.007), and intrauterine growth restriction in 1 group A versus 1 gr
47 10(-/-) mice resulted in fetal resorption or intrauterine growth restriction in response to very low
49 ging mosquito-borne virus recently linked to intrauterine growth restriction including abnormal fetal
50 trate that ZIKV(BR) infects fetuses, causing intrauterine growth restriction, including signs of micr
51 1998-1999, the authors investigated whether intrauterine growth restriction (indexed by birth weight
52 ummary, there was a weak association between intrauterine growth restriction, indexed by birth length
53 Early signs of the disease included mild intrauterine growth restriction, infantile hypotonia, an
58 OINTS: Maternal nutrient restriction induces intrauterine growth restriction (IUGR) and leads to heig
59 sts in a relatively hypoxic environment, but intrauterine growth restriction (IUGR) and pre-eclampsia
60 weight (LBW) can result from prematurity or intrauterine growth restriction (IUGR) and result in sma
66 complications such as preeclampsia (PE) and intrauterine growth restriction (IUGR) in 20% of patient
73 al ad libitum caloric intake superimposed on intrauterine growth restriction (IUGR) is associated wit
78 ry measure, we also evaluated the effects of intrauterine growth restriction (IUGR) on carotenoid sta
79 Our objective was to determine the impact of intrauterine growth restriction (IUGR) on pancreatic vas
80 duced skeletal muscle mass in the fetus with intrauterine growth restriction (IUGR) persists into adu
86 eroplacental insufficiency with asymmetrical intrauterine growth restriction (IUGR) upon fetal (22d)
87 med MIRAGE syndrome that is characterized by intrauterine growth restriction (IUGR) with gonadal, adr
88 ce also leads to decreased beta cell growth, intrauterine growth restriction (IUGR), and impaired pla
89 in patients with recurrent miscarriages and intrauterine growth restriction (IUGR), but the mediator
91 TRACT: Maternal nutrient restriction induces intrauterine growth restriction (IUGR), increasing later
92 BSTRACT: Maternal nutrient reduction induces intrauterine growth restriction (IUGR), increasing risks
94 this cell-fusion process are associated with Intrauterine Growth Restriction (IUGR), Preeclampsia (PE
103 d atherosclerosis using two mouse models for intrauterine growth restriction (IUGR): maternal protein
104 condition is characterized by short stature, intrauterine growth restriction, lipoatrophy and a facia
105 l outcomes for the fetus and newborn include intrauterine growth restriction, low birth weight, and s
108 (44%) had normal outcome, 14 (33%) developed intrauterine growth restriction of the fetus (IUGR), and
109 dies have evaluated the effect of malaria on intrauterine growth restriction on the basis of the feta
110 asion shortly after implantation, along with intrauterine growth restriction or embryonic death.
111 with various confounding factors, including intrauterine growth restriction or factors related to th
112 m either singleton gestations complicated by intrauterine growth restriction or from dizygotic twin g
113 ome (3 women had used LMWH); and 11 cases of intrauterine growth restriction or placental insufficien
114 with normal outcomes (N = 29) and those with intrauterine growth restriction or preeclampsia (N = 12)
115 horioamnionitis (OR, 4.1; 95% CI, 1.6-10.1), intrauterine growth restriction (OR, 4.0; 95% CI, 1.3-12
116 amino acid transport are decreased in human intrauterine growth restriction our data are consistent
117 DNA in amniotic fluid and/or newborn saliva, intrauterine growth restriction, preterm deliveries, and
118 ment, and pregnancy complications, including intrauterine growth restriction, preterm delivery, and s
119 priate management of pregnancies at risk for intrauterine growth restriction relies on accurate ident
120 , 0.76 [95% CI, 0.62 to 0.95]), 1% to 5% for intrauterine growth restriction (RR, 0.80 [CI, 0.65 to 0
121 a single First Nations population and causes intrauterine growth restriction, severe microcephaly, cr
122 us (ZIKV) infection in pregnant women causes intrauterine growth restriction, spontaneous abortion, a
123 nancy complications, including preeclampsia, intrauterine growth restriction, spontaneous abortion, p
124 e of the p.[P33S(;)P168S] variant in ROP and intrauterine growth restriction suggests that it also ma
125 ommon pregnancy complication associated with intrauterine growth restriction that may influence respi
126 ad evidence of severe CMV disease, including intrauterine growth restriction, ventriculomegaly, micro
127 rlying placental pathologies associated with intrauterine growth restriction, which is a significant
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。